Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jan 22, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Incyte Corp
|
0
|
—
|
—
|
—
|
0
| +1 |
Jan 18
| ||||||
Incyte Corp
| 9.67K |
—
|
—
| +5.02% | 202.07K | +1 |
Jul 14
| ||||||
Incyte Corp
| 192.4K |
—
|
—
|
∞
| 192.4K | +1 |
Jun 5
| ||||||
Fusion Pharmaceuticals Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
Incyte Corp
| 179.61K |
—
|
—
|
∞
| 179.61K | +1 |
Jun 5
| ||||||
Incyte Corp
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Rubius Therapeutics, Inc.
| -8.45K |
$0.25 | -$2,112.00 | -11.34% | 66.08K |
Feb 1
| |||||||
Rubius Therapeutics, Inc.
| 39.01K |
$0.24 | -$1,744.84 | +109.83% | 74.53K |
Jan 29 - Jan 31
| |||||||
Fusion Pharmaceuticals Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
Rubius Therapeutics, Inc.
| 14.52K |
$6.57 | -$44,236.29 | +69.14% | 35.52K |
Jan 29 - Feb 1
| |||||||
Fusion Pharmaceuticals Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 4
| |||||||
Rubius Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 29
| |||||||
Turmeric Acquisition Corp.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Fusion Pharmaceuticals Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 25
| |||||||
Fusion Pharmaceuticals Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Rubius Therapeutics, Inc.
| 21K |
$4.70 | $98,693.70 |
∞
| 21K |
Apr 14
| |||||||
Rubius Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 31
| |||||||
Crispr Therapeutics Ag
|
0
|
$33.80 | -$423,075.00 |
—
|
0
|
Nov 19
|
Scheduled
| ||||||
Crispr Therapeutics Ag
|
0
|
$30.30 | -$370,575.00 |
—
|
0
|
Nov 12
|
Scheduled
| ||||||
Crispr Therapeutics Ag
|
0
|
$28.80 | -$348,075.00 |
—
|
0
|
Oct 30
|
Scheduled
| ||||||
Crispr Therapeutics Ag
|
0
|
—
|
—
|
—
|
0
|
Jun 11
| |||||||
Rubius Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 31
| |||||||
Rubius Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 31
| |||||||
Rubius Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Crispr Therapeutics Ag
|
0
|
$33.80 | -$423,075.00 |
—
|
0
|
Jul 3 - Jul 5
|
Scheduled
| ||||||
Crispr Therapeutics Ag
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Crispr Therapeutics Ag
|
0
|
—
|
—
|
—
|
0
|
May 31
| |||||||
Crispr Therapeutics Ag
|
0
|
—
|
—
|
—
|
0
|
Oct 18
| |||||||
Crispr Therapeutics Ag
|
0
|
—
|
—
|
—
|
0
| ||||||||
Onyx Pharmaceuticals Inc
| -16.26K |
$125.00 | -$2,032,125.00 | -100.00% |
0
| +1 |
Oct 1
| ||||||
Onyx Pharmaceuticals Inc
| 16.26K |
—
|
—
|
∞
| 16.26K | +1 |
Mar 11
| ||||||
Onyx Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Allos Therapeutics Inc
| -61.37K |
—
|
—
| -70.89% | 25.2K | +1 |
Sep 30
| ||||||
Allos Therapeutics Inc
| -6.20K |
$6.63 | -$41,078.72 | -6.68% | 86.57K | +1 |
Mar 20
|
Scheduled
| |||||
Allos Therapeutics Inc
| 23.87K |
—
|
—
| +34.65% | 92.77K | +1 |
Feb 23
| ||||||
Allos Therapeutics Inc
| -6.10K |
$5.29 | -$32,270.00 | -8.13% | 68.9K | +1 |
Mar 20
|
Scheduled
| |||||
Allos Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 25
| ||||||
Allos Therapeutics Inc
| 75K |
—
|
—
|
∞
| 75K | +1 |
Mar 19
| ||||||
Allos Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Osi Pharmaceuticals Inc
| 6.7K |
—
|
—
| +67,000.00% | 6.71K |
Dec 13
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.